Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-18-000676

Options or other derivatives

  • Director acquired 15,404 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Farokhzad Omid · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-06-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +15,404 $12.75 2028-06-14 15,404 15,404 D
Loading xslF345X03/doc4_5481.xml…